Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departmentsLuca Laurenti, Giovanni D’Arena, Idanna Innocenti et al.|Leukemia Research|2015Cited by 31
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL studyMassimo Gentile, Valter Gattei, Fortunato Morabito et al.|Leukemia|2020Cited by 24
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA studyIdanna Innocenti, Luca Laurenti, Marina Deodato et al.|Haematologica|2022Cited by 20
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12Francesco Autore, Luca Laurenti, Paolo Strati et al.|Cancers|2019Cited by 18
Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL studyFortunato Morabito, Massimo Gentile, Giovanni Tripepi et al.|American Journal of Hematology|2021Cited by 14